A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia

NCT04955678 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperkalemia

Interventions

DRUG: Calcium, hydrolysed divinylbenzene-Me 2-fluoro-2-propenoate-1, 7-octadiene polymer sorbitol complexes
DRUG: Placebo

Sponsor

Zeria Pharmaceutical